Jean B. Dekernion
#150,077
Most Influential Person Now
Jean B. Dekernion's AcademicInfluence.com Rankings
Jean B. Dekernionphilosophy Degrees
Philosophy
#8262
World Rank
#11605
Historical Rank
Logic
#5297
World Rank
#6684
Historical Rank
Download Badge
Philosophy
Why Is Jean B. Dekernion Influential?
(Suggest an Edit or Addition)Jean B. Dekernion's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. (1998) (1176)
- Expression of cellular oncogenes in human malignancies. (1984) (829)
- Improved prognostication of renal cell carcinoma using an integrated staging system. (2001) (673)
- Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. (2002) (592)
- The natural history of metastatic renal cell carcinoma: a computer analysis. (1978) (511)
- Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. (2000) (459)
- Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. (1994) (453)
- The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. (1994) (400)
- Prognostic factors in metastatic renal carcinoma. (1986) (345)
- COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE CANCER: RESULTS OF A MULTICENTER CLINICAL TRIAL OF 6,630 MEN (1994) (326)
- Low p27 expression predicts poor disease-free survival in patients with prostate cancer. (1998) (316)
- Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. (1999) (315)
- Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves. (1994) (314)
- Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. (1999) (303)
- Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. (1997) (280)
- Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. (1994) (263)
- Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. (1992) (225)
- Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. (1993) (218)
- Clinical management of foreign bodies of the genitourinary tract. (2000) (199)
- Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. (2003) (187)
- Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone (1983) (162)
- The treatment of renal cell carcinoma with human leukocyte alpha-interferon. (1983) (162)
- Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. (1995) (161)
- Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen. (1997) (160)
- Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. (1994) (155)
- Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor. (1997) (153)
- Positron emission tomography in urological oncology. (1998) (145)
- Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. (2000) (143)
- Predictors of metastatic disease in men with biochemical failure following radical prostatectomy. (2004) (135)
- The Diagnosis and Treatment of Renal Cell Carcinoma (1980) (134)
- Prognostic implications of vena caval extension of renal cell carcinoma. (1982) (134)
- The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. (1993) (133)
- Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. (2000) (131)
- Treatment of advanced renal cell carcinoma--traditional methods and innovative approaches. (1983) (126)
- Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer. (1995) (124)
- Treatment with finasteride following radical prostatectomy for prostate cancer. (1995) (120)
- Carcinoma of the penis (1973) (119)
- Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma. (1992) (116)
- Mathematical model to predict individual survival for patients with renal cell carcinoma. (2002) (107)
- Renal cell carcinoma: recent progress and future directions. (1997) (105)
- Long-term effects of finasteride on prostate tissue composition. (1999) (104)
- The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guerin. (1985) (104)
- Three-dimensional ultrasound device for rapid determination of bladder volume. (1997) (103)
- Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biology. (2001) (99)
- Prognosis of patients with stage D1 prostate carcinoma following radical prostatectomy with and without early endocrine therapy. (1990) (98)
- Chemotherapy Programs of the National Prostatic Cancer Project (NPCP) (1980) (86)
- Cancer‐specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989‐2005) (2008) (85)
- Bilateral renal cell carcinoma and renal cell carcinoma in the solitary kidney. (1984) (84)
- The value of computerized tomography scan and magnetic resonance imaging in staging prostatic carcinoma: comparison with the clinical and histological staging. (1986) (83)
- Neoadjuvant hormonal deprivation in patients with locally advanced prostate cancer. (1993) (82)
- Bladder neoplasms associated with augmentation cystoplasty: report of 2 cases and literature review. (1989) (81)
- Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands. (1994) (77)
- Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer. (1983) (77)
- Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients. (1997) (77)
- Treatment of advanced renal cell carcinoma. (1982) (75)
- Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma. (1980) (73)
- Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate. (1988) (72)
- Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines. (1999) (72)
- Diagnosis and treatment of prostate cancer. (1998) (70)
- Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation. (1988) (65)
- Autologous Tumor-Specific Cytotoxicity of Tumor-Infiltrating Lymphocytes Derived from Human Renal Cell Carcinoma (1991) (65)
- Surgical treatment of Peyronie's disease: a new approach. (1976) (63)
- Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. (1996) (62)
- The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate (1987) (62)
- Comparison of estramustine phosphate and vincristine alone or in combination for patients with advanced, hormone refractory, previously irradiated carcinoma of the prostate. (1981) (61)
- Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial. (1985) (61)
- Intraurethral prostaglandin E-2 cream: a possible alternative treatment for erectile dysfunction. (1993) (60)
- CL1-GFP: an androgen independent metastatic tumor model for prostate cancer. (2000) (59)
- Detection of local recurrence after radical prostatectomy by prostate specific antigen and transrectal ultrasound. (1992) (58)
- Interferon-α Primed Tumor-Infiltrating Lymphocytes Combined with Interleukin-2 and Interferon-α as Therapy for Metastatic Renal Cell Carcinoma (1993) (58)
- Adjuvant radiotherapy in patients post-radical prostatectomy with tumor extending through capsule or positive seminal vesicles. (1992) (58)
- The natural history and clinical features of renal carcinoma. (1987) (56)
- Current management of renal cell carcinoma (1996) (55)
- Specific immunotherapy with suppressor function inhibition for metastatic renal cell carcinoma. (1986) (55)
- A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area. (1983) (54)
- Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage. (2000) (53)
- Interleukin-6 and renal cell cancer: Production, regulation, and growth effects (2005) (53)
- Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial. (2000) (53)
- Cost-efficient radical prostatectomy with a clinical care path. (1996) (52)
- Quantitative Polymerase Chain Reaction Does not Improve Preoperative Prostate Cancer Staging: A Clinicopathological Molecular Analysis of 121 Patients (1998) (52)
- Intraoperative frozen section monitoring of nerve sparing radical retropubic prostatectomy. (1999) (52)
- Risk of urinary incontinence following radical prostatectomy. (1983) (52)
- Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia. (1996) (50)
- Controversies in ilioinguinal lymphadenectomy for cancer of the penis. (1992) (49)
- Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing. (1985) (49)
- Salvage radical prostatectomy after failure of curative radiotherapy for adenocarcinoma of prostate. (1992) (48)
- Effect of chemotherapeutic agents on bladder cancer: a new animal model. (1973) (48)
- Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia. (1997) (47)
- Prostatic specific antigen related to clinical status 1 to 14 years after radical retropubic prostatectomy. (1991) (47)
- Malignant melanoma metastatic to the bladder. Regression following intratumor injection of BCG vaccine. (1974) (44)
- Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score. (2002) (41)
- Use of fine needle aspiration for detection of stage A prostatic carcinoma before transurethral resection of the prostate: a clinical trial. (1987) (41)
- Metastatic carcinoma to penis: when is total penectomy indicated? (1987) (41)
- A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostate. (1981) (40)
- Na,K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma. (2008) (40)
- Dominant B cell epitope from NY‐ESO‐1 recognized by sera from a wide spectrum of cancer patients: Implications as a potential biomarker (2005) (40)
- Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacy. (1996) (39)
- Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. (2004) (39)
- PROSTATE TISSUE COMPOSITION AND RESPONSE TO FINASTERIDE IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (1998) (38)
- Urinary retention after orthotopic neobladder substitution in females. (2011) (37)
- Murine hybridoma antibodies against human transitional carcinoma-associated antigens. (1984) (37)
- The chemotherapy of advanced bladder carcinoma. (1977) (37)
- Pitfalls in preoperative staging in prostate cancer. (1987) (36)
- Prognostic significance of the DNA content of renal carcinoma (1989) (35)
- Advanced renal cell carcinoma: treatment with xenogeneic immune ribonucleic acid and appropriate surgical resection. (1976) (34)
- Renal cell carcinoma: basic biology and current approaches to therapy. (1991) (33)
- Role of lymphadenectomy for patients undergoing radical nephrectomy for renal cell carcinoma. (2003) (33)
- Management of advanced testicular seminoma. (1979) (33)
- Alum irrigation for severe bladder hemorrhage. (1986) (32)
- Immune RNA Therapy for Renal Cell Carcinoma: Survival and Immunologic Monitoring (1977) (32)
- The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinoma. (1991) (31)
- Result of treatment of patients with stage D1 prostatic carcinoma. (1985) (31)
- Failure of ascorbic acid to inhibit FANFT-induced bladder cancer. (1975) (30)
- Cost effective analysis of prenephrectomy radioisotope scans in renal cell carcinoma. (1983) (29)
- Chemotherapy of experimental transitional-cell carcinoma. (1974) (28)
- Selection of initial therapy for renal cell carcinoma (1987) (28)
- Pathology, biology, and clinical staging of renal cell carcinoma. (1989) (28)
- The natural history of renal cell carcinoma. (1989) (28)
- Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapy. (1996) (28)
- Serum-free medium for the in vitro growth of normal and malignant urinary bladder epithelial cells. (1982) (26)
- Early versus delayed lymph-node dissection versus no lymph-node dissection in carcinoma of the penis. (1987) (24)
- Transitional cell carcinoma of bladder in first four decades of life. (1982) (24)
- Cost-effective analysis of pre-cystectomy radioisotope scans. (1982) (23)
- The effects of granulocyte-macrophage colony-stimulating factor on tumour-infiltrating lymphocytes from renal cell carcinoma. (1995) (23)
- Significance of histological prognostic indicators in patients with carcinoma of the prostate. (1990) (23)
- Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development. (2004) (22)
- Transcatheter embolization of advanced renal cell carcinoma with radioactive seeds. (1981) (22)
- The detection and clinical significance of antibodies to tumor-associated antigens in patients with renal cell carcinoma. (1979) (22)
- Growth stimulating activity produced by human bladder cancer cells. (1984) (21)
- Spontaneous regression of liver metastasis from renal carcinoma. (1988) (21)
- Acute scrotal pain and swelling in children: a surgical emergency. (1981) (21)
- Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivo. (1994) (21)
- Treatment of advanced seminoma with pre-radiation chemotherapy. (1983) (20)
- Lymphadenectomy for renal cell carcinoma. Therapeutic implications. (1980) (20)
- Immunotherapy for advanced renal cell cancer: the role of radical nephrectomy. (1990) (20)
- The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate. (1987) (19)
- Preoperative endoscopic diagnosis of fibroepithelial polyp of the renal pelvis: a case report and review of the literature. (1991) (19)
- Derivation and application of upper limits for prostate specific antigen in men aged 50-74 years with no clinical evidence of prostatic carcinoma. (1995) (19)
- The expression of C-jun and junB mRNA in renal cell cancer and in vitro regulation by transforming growth factor beta 1 and tumor necrosis factor alpha 1. (1992) (19)
- Cell surface blood group antigens in prostatic carcinoma. (1984) (18)
- Intraoperative Frozen Section Monitoring of Nerve Sparing Radical Retropubic Prostatectomy (2000) (17)
- Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinoma. (1993) (17)
- Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma. (2000) (17)
- Subepithelial hematoma of the renal pelvis (Antopol-Goldman lesion): a case report and review of the literature. (1984) (17)
- Work in progress: transcatheter embolization of renal cell carcinoma with radioactive infarct particles. (1983) (17)
- In Vivo Imaging of Intraprostatic-Specific Gene Transcription by PET (2011) (16)
- Carcinoma of the penis (1976) (16)
- The Kock pouch as a urinary reservoir. Pitfalls and perspectives. (1985) (16)
- Tensor fascia lata myocutaneous flap for coverage of skin defect after radical groin dissection for metastatic penile carcinoma. (1982) (16)
- Chemotherapy of Bladder Cancer (1985) (15)
- Detection of onco-fetal bladder antigen in urine of patients with transitional cell carcinoma. (1987) (15)
- Ultrasound-based combination therapy: potential in urologic cancer (2011) (15)
- Early post-operative morbidity of total prostatectomy. (1989) (15)
- Surgical treatment of Peyronie's disease: a new approach (1978) (15)
- Acute effects of orally administered levamisole on random monocyte motility and chemotaxis in man. (1978) (15)
- Cytological grading of prostatic aspiration biopsy: a comparison with the Gleason grading system. (1987) (14)
- The effect of bacillus Calmette-Guerin on the urinary system of pigs. (1987) (14)
- The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate (1983) (14)
- Human reproductive tissues contain thyrotropin releasing hormone (TRH) and TRH-homologous peptides. (1983) (13)
- Metastatic renal cell cancer: interleukin-2 toxicity induced by contrast agent injection. (1991) (13)
- Soluble tumor necrosis factor receptor expression in patients with metastatic renal cell carcinoma treated with interleukin-2-based immunotherapy. (1993) (13)
- Long-term effect of intravesical bacillus Calmette-Guérin (BCG) Tice strain on flat carcinoma in situ of the bladder. (1989) (13)
- Open Radical Nephrectomy for Localized Renal Cell Carcinoma (2008) (13)
- Invasive giant condylomata acuminata: a case report. (1989) (12)
- Chemotherapy programs of the National Prostatic Cancer Project (NPCP). (1980) (12)
- Carcinoma of the penis (1976) (12)
- Immune cytolysis of human renal carcinoma mediated by xenogeneic immune ribonucleic acid. (1976) (12)
- Immunotherapy of cancer with "immune" RNA: current status. (1974) (10)
- Immunotherapy in Renal Cell Carcinoma; Cellular Immunotherapy (1996) (10)
- Treatment of skeletal metastases from urologic malignancies. (1978) (10)
- Computer-generated graphical presentations: use of multimedia to enhance communication. (1997) (9)
- Treatment of late complications of ileal conduit. (1969) (9)
- A bladder tumor model response to immunotherapy. (1978) (9)
- The response of metastatic retroperitoneal seminoma to chemotherapy. (1977) (9)
- Primary small cell carcinoma of the augmented urinary bladder. (1992) (9)
- The significance of atypia in fine needle aspiration cytology of the prostate. (1988) (9)
- Clinical Urology: Letter to the EditorIn Reply: Re: Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves (1996) (9)
- Preliminary report of the use of levamisole in the treatment of bladder cancer. (1978) (8)
- Immunotherapy for malignant lesions in man using immunogenic ribonucleic acid. (1975) (7)
- Chemotherapy of hormonally unresponsive prostatic carcinoma. (1984) (7)
- The treatment of patients with metastatic melanoma and renal cell cancer using in vitro expanded and genetically-engineered (neomycin phosphotransferase) bulk, CD8(+) and/or CD4(+) tumor infiltrating lymphocytes and bulk, CD8(+) and/or CD4(+) peripheral blood leukocytes in combination with recombina (1992) (6)
- Patch grafting the renal pelvis and ureteropelvic junction (2004) (6)
- Intracellular localization of anti-tumor immune RNA. (1976) (6)
- Intracellular localization of antitumor "immune" RNA. (1974) (6)
- Levamisole in the treatment of non-invasive and invasive bladder cancer: a preliminary report. (1978) (6)
- Modulation of tumor-infiltrating lymphocytes derived from human renal cell carcinoma by interleukin-4. (1992) (6)
- The effects of interleukin-6 on tumor-infiltrating lymphocytes derived from human renal cell cancer. (1991) (6)
- Editorial: Perspectives on the Problem of Prostate Cancer (1994) (5)
- Editorial Comment: Laparoscopic Nephrectomy for Renal-Cell Carcinoma: The Current Situation (2001) (5)
- Conservative treatment of diffuse carcinoma in situ of the bladder with repeated courses of intravesical therapy. (1989) (5)
- Bridging the gap: Health disparity research initiatives through the department of defense (DOD) congressionally directed medical research programs (CDMRP) prostate cancer research program (PCRP) (2005) (5)
- Reexamination of current staging for renal cell carcinoma. (2005) (5)
- Adjuvant endocrine therapy after radical prostatectomy for stage D1 prostate carcinoma. (1990) (5)
- The creation and care of enterocutaneous stomas (1975) (5)
- Immune cytolysis of human neoplasms mediated by RNA. (1975) (4)
- Preliminary studies of specific immunotherapy of cancer with immune RNA. (1977) (4)
- VALIDATION OF A NOMOGRAM FOR PREDICTING DISEASE RECURRENCE FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER (1999) (4)
- Renal cell carcinoma: physiology, diagnosis, and therapy (1991) (4)
- Investigation of blood group antigens and carcinoembryonic antigen in urinary bladder carcinoma. (1986) (4)
- Immunotherapy for renal cell carcinoma. (1992) (4)
- The operable renal cell carcinoma: summary and conclusions. (1990) (3)
- Adjuvant therapy for genitourinary cancer. (1981) (3)
- Growth characteristics of the stilbestrol‐induced hamster kidney tumor (1971) (3)
- Preliminary studies of specific immunotherapy of cancer with immune RNA (1977) (3)
- Immunotherapy for metastatic renal-cell carcinoma (1991) (3)
- Incidental renal neoplasms: incidence in Los Angeles County, treatment and prognosis. (1988) (3)
- Antibodies to cultured tumor cells detected in sera of renal cell carcinoma patients by a quantitative avidin-biotin method. (1986) (3)
- POSITRON EMISSION TOMOGRAPHY (PET), COMPUTED TOMOGRAPHY (CT), AND MONOCLONAL ANTIBODY SCAN (MAb) FOR EVALUATION OF LYMPH NODE METASTASES IN PATIENTS WITH PROSTATE SPECIFIC ANTIGEN (PSA) RELAPSE AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER. (1998) (2)
- Immunotherapy of renal cell carcinoma. (1992) (2)
- Carcinoma of the penis and scrotum (1994) (2)
- Response of tumors to biologic modifiers and chemotherapeutic agents. (1983) (2)
- Editorial: Prostate Cancer (1996) (2)
- Investigation of Blood Group Antigens and Carcinoembryonic Antigen in Urinary Bladder Carcinoma (1987) (2)
- LOW P27 PROTEIN EXPRESSION INDEPENDENTLY PREDICTS POOR DISEASE FREE SURVIVAL IN PATIENTS WITH POSITIVE SURGICAL MARGINS FOLLOWING RADICAL PROSTATECTOMY (1999) (2)
- Regulatory effects of interleukin-4 on tumor-infiltrating lymphocytes derived from human renal cell carcinoma. (1992) (2)
- Predicting pathological stage of localized prostate cancer. (1997) (2)
- Pathologic response and long term results of preoperative M-VAC regimen in regionally advanced transitional cell carcinoma of the bladder. (1993) (2)
- Dietary boron intake and reduced risk of prostate cancer (2002) (2)
- IMMUNOTHERAPY OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (RCCa) USING INTERLEUKIN-2 (IL-2) BASED THERAPY ADMINISTERED EITHER ALONE OR WITH IN VIVO PRIMED OR CD8+ SELECTED TUMOR INFILTRATING LYMPHOCYTES (TIL): THE UCLA EXPERIENCE (1993) (1)
- Antitumor effect of heat-killed Aspergillus fumigatus mycelium in a mouse model (2004) (1)
- Treatment of hypernephroma with xenogeneic immune RNA. (1978) (1)
- Urologic Applications of Regional Chemotherapy (1986) (1)
- The management of stage C prostate cancer. (1987) (1)
- A five-year analysis of the New Investigator Award mechanism of the Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP) Prostate Cancer Research Program (PCRP) (2005) (1)
- Growth inhibition by chemotherapeutic agents on stilbestrol-induced hamster kidney tumor. (1971) (1)
- Routine or Ultrasound-Guided Biopsy for a Benign Prostatic Lesion (1991) (1)
- This Month in Investigative Urology: Treatment of Rat Prostatic Adenocarcinoma with Medroxyprogesterone Acetate (1991) (1)
- Genitourinary Cancer Management (1987) (1)
- Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical Prostatectomy (2015) (1)
- Unusual case of urethral carcinoma. (1981) (1)
- Virus-induced genitourinary malignancy. Macromolecular identity. (1973) (1)
- Staging of Renal Cell Carcinoma (1988) (1)
- Intravesical bacillus Calmette-Guérin and second primary malignancies. (1989) (1)
- Renal cell carcinoma. (1986) (1)
- Ischemia of neobladder. Clinical manifestations and management. (1993) (1)
- Identification and therapy of stage B prostate carcinoma. (1987) (1)
- The influence of dactinomycin on compensatory renal hypertrophy. (1973) (1)
- Preliminary results on the use of the humoral immune response as a serum marker in patients with bladder tumors (2004) (1)
- The therapy of renal adenocarcinoma with immune RNA. (1980) (1)
- PET IMAGING IN PATIENTS WITH BIOCHEMICAL FAILURE FOLLOWING TREATMENT FOR LOCALIZED PROSTATE CANCER (1998) (0)
- Critical Utility of Ultrasensitive PSA for High-Risk Patients Eligible for Adjuvant Radiation Therapy Following Radical Prostatectomy (2012) (0)
- Perspectives on the problem of prostate cancer. (1994) (0)
- Prostate cancer. (1996) (0)
- Hypernephroma--natural history and the influence of immunotherapy. (1977) (0)
- RE: QUANTITATIVE POLYMERASE CHAIN REACTION DOES NOT IMPROVE PREOPERATIVE PROSTATE CANCER STAGING (1998) (0)
- FOR HIGHER SPECIFIC KILLING BY TNF-SECRETORS IN VITRO (1993) (0)
- Metastatic renal cell carcinoma: systemic treatment. (1996) (0)
- 1015: Seamless, Simultaneous Electronic Clinical Database Entry and Clinical Note Generation for Prostate Cancer: A Glimpse into the Future of Retrospective Clinical Research and Medical Documentation (2005) (0)
- PREDICTING PATHOLOGICAL STAGE OF LOCALIZED PROSTATE CANCER. AUTHORS' REPLY (1997) (0)
- Legends in urology. (2011) (0)
- 736 PRO-INFLAMMATORY AND MITOGENIC ACTIVITY OF PERIPROSTATIC ADIPOSE TISSUE IN PROSTATE CANCER (2011) (0)
- CYTOKINE (CK) RELEASE PATTERN UPON AUTOLOGOUS TUMOR STIMULATION OF RENAL TUMOR-INFILTRATING LYMPHOCYTES (TIL): EVIDENCE FOR HIGHER SPECIFIC KILLING BY TNFSECRETORS IN VITRO (1993) (0)
- The Role of Combination Biologic Therapy in the Immunotherapeutic Approach to the Treatment of Renal Cell Carcinoma (1992) (0)
- 150 THE NATURAL HISTORY OF ULTRASENSITIVE PSA FOLLOWING RADICAL PROSTATECTOMY (2011) (0)
- The Use of Cytokines, Tumor Infiltrating Lymphocytes, and Gene Therapy in the Treatment of Advanced Renal Cell Carcinoma: The UCLA Experience (1995) (0)
- THERAPEUTIC IRRADIATION FOR PATIENTS WITH AN ELEVATED POST-PROSTATECTOMY PROSTATE SPECIFIC ANTIGEN LEVEL: EDITORIAL COMMENT (1997) (0)
- The surgical treatment of renal cell carcinoma. (1977) (0)
- TRANSITIONAL-CELL CARCINOMA* (1974) (0)
- Kidney tumors — What's new? (1995) (0)
- RE: RECURRENCE PATTERNS AFTER RADICAL RETROPUBIC PROSTATECTOMY (1998) (0)
- Local response and long-term results of preoperative M-VAC regimen in regionally advanced transitional cell carcinoma of the bladder. (1993) (0)
- Immunotherapy of human malignancies with immune RNA (1977) (0)
- Prostate cancer. (2020) (0)
- BCG-induced enhancement of tumor growth in experimental bladder tumor model. (1982) (0)
- Renal masses. (1985) (0)
- Editorial Comment: Evaluation and Management of Parastomal Hernia in Association With Continent Urinary Diversion (1997) (0)
- Invasive bladder cancer: bladder salvage and reconstruction (1996) (0)
- Aspiration biopsy of the prostate: the urologist's viewpoint. (1983) (0)
- Quality of life in men with prostate cancer A pilot study (1993) (0)
- Jean B. DeKernion--a gentleman chairman. Interview by Arnold I. Chin. (2012) (0)
- Original Articles INTRAOPERATIVE FROZEN SECTION MONITORING OF NERVE SPARING RADICAL RETROPUBIC PROSTATECTOMY (1999) (0)
- Immunology of genitourinary malignancies. (1977) (0)
- IL-2 Progress in Research and Treatment of Prostate Cancer (2007) (0)
- TREATMENT OF METASTATIC RENAL CELL CARCINOMA WITH CD8( +) SELECTED TUMOR INFILTRATING LYMPHOCYTES FROM PRIMARY TUMOR NEPHRECTOMY, INTERLEUKIN-2 AND CYTOKINE-PRIMED OR (1997) (0)
- Society of Urologic Oncology: Whitmore lecture. (2006) (0)
- An improved glass tracheostomy tube. (1969) (0)
- [Adoptive immunotherapy and metastasized cancer of the kidney. Regulator effects of interleukin-4 on tumor infiltrating lymphocytes (TIL)]. (1991) (0)
- IL3 Immunotherapy of Urologic Cancer : Progress and Promise (2010) (0)
- The diagnosis and treatment of renal cell carcinoma. (1980) (0)
- Prostate cancer: some issues of treatment and tumor behavior. (1995) (0)
- Surgery from a US perspective. (1995) (0)
- Re: Deoxyribonucleic acid content and medroxyprogesterone acetate treatment in metastatic renal cell carcinoma. (1990) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jean B. Dekernion?
Jean B. Dekernion is affiliated with the following schools:
